Higher Genotyping Performance of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit Against ViroSeq HIV-1 Genotyping Kit in HIV <i>Protease</i>, <i>Reverse Transcriptase</i>, and <i>Integrase</i> Regions. [PDF]
Choga OT+7 more
europepmc +1 more source
Unique molecular signatures in rebound viruses from antiretroviral drug and CRISPR-treated HIV-1-infected humanized mice. [PDF]
Zhang C+4 more
europepmc +1 more source
The Meandrous Route of Rilpivirine in the Search for the Miraculous Drug to Treat HIV Infections. [PDF]
De Clercq E.
europepmc +1 more source
The cumulative prevalence of HIV-1 drug resistance in perinatal HIV. [PDF]
Glenn JS+6 more
europepmc +1 more source
Weight loss with real-world doravirine use in the OPERA cohort: a US-based cohort study. [PDF]
Mounzer K+7 more
europepmc +1 more source
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial. [PDF]
Ombajo LA+7 more
europepmc +1 more source
Related searches:
Resistance to HIV integrase inhibitors
Current Opinion in HIV and AIDS, 2012HIV integrase inhibitors are potent antiretroviral drugs that efficiently decrease viral load in patients. Emergence of resistance mutations against this new class of drugs represents a threat to their long-term efficacy. The purpose of this review is to provide new information about the most recent mutations identified and other mutations that confer ...
Peter K. Quashie+2 more
openaire +6 more sources